AVADEL PHARMACEUTICALS PLC
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
AVDL | US
Overview
Corporate Details
- ISIN(s):
- IE00BDGMC594
- LEI:
- Country:
- United States of America
- Address:
- 10 EARLSFORT TERRACE, DUBLIN 2
- Website:
- https://www.avadel.com/
- Sector:
- Manufacturing
Description
Avadel Pharmaceuticals PLC is a biopharmaceutical company focused on developing and commercializing therapies for sleep disorders, with a primary focus on narcolepsy. The company's lead product is LUMRYZ™, an extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Avadel's core strategy involves applying innovative solutions to drug development to address the challenges and unmet needs patients face with current treatment options, aiming to disrupt existing treatment paradigms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AVADEL PHARMACEUTICALS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AVADEL PHARMACEUTICALS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AVADEL PHARMACEUTICALS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
